Can a patient with Graves disease safely use Zicam (zinc nasal spray) or oral zinc supplements, and could these affect thyroid function or Graves disease management?

Zicam and Graves Disease

Patients with Graves disease can safely use Zicam nasal spray, as the current formulation is zinc-free, but should exercise caution with oral zinc supplements due to potential effects on thyroid function and autoimmune activity.

Key Product Information

The current Zicam Cold Remedy Nasal Spray is zinc-free 1. This is a critical distinction from older formulations. The zinc-free nasal spray poses no direct thyroid-related concerns for patients with Graves disease.

Oral Zinc Supplementation Considerations

Evidence on Zinc and Thyroid Function

The relationship between zinc and thyroid disease is complex and bidirectional:

• Zinc affects thyroid hormone metabolism: Zinc supplementation can increase thyroid hormone levels, particularly T3, in zinc-deficient individuals 2. In two zinc-deficient women, 26.4 mg/day of zinc gluconate increased total T3 concentrations and resting metabolic rate over 4 months.

• Graves disease depletes zinc: Patients with active Graves disease have significantly lower red blood cell zinc concentrations (7.3 ± 1.6 mg/L) compared to euthyroid controls (12.6 ± 1.3 mg/L) 3. This depletion reflects chronic hyperthyroidism.

Recent Concerning Data on Autoimmune Risk

A 2025 study found that higher dietary zinc intake is an independent risk factor for autoimmune thyroiditis 4. Individuals with autoimmune thyroid disease had significantly higher dietary zinc intake (22.6 mg vs. 15.3 mg, P < .001). The mechanism may involve disruption of immune balance, potentially increasing autoimmune disease risk.

Clinical Implications for Graves Disease

For patients with active, untreated Graves disease: Avoid zinc supplementation above dietary intake. The priority is achieving euthyroidism with standard treatments (methimazole, radioactive iodine, or thyroidectomy) [@2,3,4@]. Excess iodine—not zinc—is the primary micronutrient concern, as it can worsen hyperthyroidism 5.

For patients with treated, stable Graves disease:

• If zinc deficiency is documented (low serum or RBC zinc), modest supplementation may be considered
• However, given the 2025 data linking higher zinc intake to autoimmune thyroid disease risk 4, limit supplementation to correcting documented deficiency only
• Monitor thyroid function tests if zinc supplementation is initiated

Antioxidant Context

One study showed that antioxidant supplementation (vitamins C, E, beta-carotene, and selenium—not zinc alone) alongside methimazole helped patients achieve euthyroidism faster 6. However, this was a combination therapy, not zinc-specific.

Practical Algorithm

1. Zicam nasal spray (zinc-free formulation): Safe to use—no thyroid concerns
2. Oral zinc supplements:
   • Active Graves disease: Avoid supplementation; focus on standard hyperthyroidism treatment
   • Stable, treated Graves disease: Only supplement if documented zinc deficiency exists
   • Dosing if needed: Use minimal doses to correct deficiency (typically 15-25 mg/day elemental zinc)
   • Monitor: Check thyroid function tests 1-2 months after starting zinc

Critical Pitfalls

• Do not confuse old zinc-containing Zicam formulations with current zinc-free products 1
• Avoid excessive zinc intake (>40 mg/day from all sources) given autoimmune concerns 4
• Distinguish zinc from iodine: Excess iodine is the primary micronutrient that worsens Graves disease and requires beta-blockers ± methimazole for treatment [@2,3,4@]
• Zinc supplementation does not treat Graves disease—standard therapies (antithyroid drugs, radioactive iodine, surgery) remain essential [@13,16@]